First ever treatment to delay type 1 diabetes is licensed in the US – Diabetes UK
0345123 2399customer supportThe US Food and Drugs Administration (FDA) has approved the world’s first ever immunotherapy for type 1 diabetes, teplizumab, also called Tzield. This is the biggest treatment breakthrough…